IDO1 and cancer: Indoleamine-2,3-dioxygenase (IDO) is an enzyme able to catalyze the first and rate-limiting reaction of the essential amino acid l-tryptophan (trp) conversion into l-kynurenine (kyn), inducing an immunosuppressive microenvironment in cancers (20).